Subscribe
flocu
flocu / iStockphoto.com
13 September 2017Americas

Teva sells Paragard contraceptive for $1.1bn

Medical device firm Cooper Companies has agreed to acquire the global rights to Teva’s Paragard intrauterine device (IUD) for $1.1 billion.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Teva and generics in SPC win against MSD
23 March 2017   The English High Court has ruled that a supplementary protection certificate owned by Merck Sharp & Dohme is invalid because it didn’t comply with European regulations.
Americas
Teva and Amneal lose patent battle against Mallinckrodt
10 October 2016   Ireland-based biopharmaceutical company Mallinckrodt and Endo, a US healthcare business, have won a patent case against Amneal and Teva.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

More on this story

Big Pharma
Teva and generics in SPC win against MSD
23 March 2017   The English High Court has ruled that a supplementary protection certificate owned by Merck Sharp & Dohme is invalid because it didn’t comply with European regulations.
Americas
Teva and Amneal lose patent battle against Mallinckrodt
10 October 2016   Ireland-based biopharmaceutical company Mallinckrodt and Endo, a US healthcare business, have won a patent case against Amneal and Teva.

More on this story

Big Pharma
Teva and generics in SPC win against MSD
23 March 2017   The English High Court has ruled that a supplementary protection certificate owned by Merck Sharp & Dohme is invalid because it didn’t comply with European regulations.
Americas
Teva and Amneal lose patent battle against Mallinckrodt
10 October 2016   Ireland-based biopharmaceutical company Mallinckrodt and Endo, a US healthcare business, have won a patent case against Amneal and Teva.

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York